PETNet Solutions of Knoxville, TN, has signed an agreement with GlaxoSmithKline in which PETNet provides PET facilities and services to the pharmaceutical giant.
As part of the deal, PETNet will supply PET isotopes to a GlaxoSmithKline pre-clinical research site located in Mt. Vernon, U.K. Additionally, the firm will have the option, at GlaxoSmithKline’s sole discretion, to license diagnostic PET probes that are developed by GlaxoSmithKline, according to PETNet, a subsidiary of PET developer CTI Molecular Imaging.
By AuntMinnie.com staff writersMarch 2, 2004
Related Reading
PETNet renews Merck agreement, February 12, 2004
CTI continues growth in Q1, February 3, 2004
PETNet Solutions partners with Yerkes, January 28, 2004
PETNet signs deal with Johns Hopkins, January 27, 2004
CTI unveils Reveal Hi REZ for PET/CT, November 30, 2003
Copyright © 2004 AuntMinnie.com
